Medicare Enrolled
Dr. Ashwini Gandhe, M.D.
Internal Medicine · Aliquippa, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gandhe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gandhe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gandhe
Dr. Ashwini Gandhe is an internal medicine specialist in Aliquippa, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gandhe performed 520 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gandhe received a total of $11,812 from 67 pharmaceutical and/or device companies across 772 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gandhe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 520 Medicare services
$11,812 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗520
Medicare services
Bottom 48% in PA for internal medicine
Not available
Unique patients (not deduplicated)
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
267 | $77 | $204 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
73 | $121 | $319 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
45 | $72 | $163 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
45 | $29 | $36 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $120 | $291 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
25 | $8 | $16 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
14 | $8 | $48 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $55 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,812
Total received (2018-2024)
Avg $1,687/year across 7 years
Top 7% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
772
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,737
2023
$1,612
2022
$1,608
2021
$1,817
2020
$1,282
2019
$1,740
2018
$2,017
Payments by company (2024)
Novo Nordisk Inc
$348
ABBVIE INC.
$284
GlaxoSmithKline, LLC.
$208
Lilly USA, LLC
$114
PFIZER INC.
$100
Amgen Inc.
$82
AstraZeneca Pharmaceuticals LP
$78
Janssen Pharmaceuticals, Inc
$74
Phathom Pharmaceuticals, Inc.
$56
VIVUS LLC
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Mylan Specialty L.P.
$46
E.R. Squibb & Sons, L.L.C.
$34
Abbott Laboratories
$34
Paratek Pharmaceuticals, Inc.
$33
SANOFI PASTEUR INC.
$26
Otsuka America Pharmaceutical, Inc.
$21
Eisai Inc.
$20
Dexcom, Inc.
$19
Xeris Pharmaceuticals, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
TheracosBio, LLC
$17
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,584
GlaxoSmithKline, LLC.
$1,311
ABBVIE INC.
$958
AstraZeneca Pharmaceuticals LP
$763
Boehringer Ingelheim Pharmaceuticals, Inc.
$678
Lilly USA, LLC
$639
PFIZER INC.
$545
Amgen Inc.
$477
Janssen Pharmaceuticals, Inc
$427
Merck Sharp & Dohme Corporation
$319
Astellas Pharma US Inc
$263
AbbVie Inc.
$261
Horizon Therapeutics plc
$209
SANOFI-AVENTIS U.S. LLC
$190
Amarin Pharma Inc.
$184
Takeda Pharmaceuticals U.S.A., Inc.
$182
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$169
E.R. Squibb & Sons, L.L.C.
$162
Horizon Pharma plc
$148
Novartis Pharmaceuticals Corporation
$137
Abbott Laboratories
$124
Teva Pharmaceuticals USA, Inc.
$117
Bayer HealthCare Pharmaceuticals Inc.
$111
VIVUS LLC
$103
Eisai Inc.
$102
Sunovion Pharmaceuticals Inc.
$91
Kowa Pharmaceuticals America, Inc.
$90
Allergan Inc.
$89
Mylan Specialty L.P.
$82
Merck Sharp & Dohme LLC
$80
Currax Pharmaceuticals LLC
$76
Allergan, Inc.
$74
Xeris Pharmaceuticals, Inc.
$60
Avanir Pharmaceuticals, Inc.
$59
Otsuka America Pharmaceutical, Inc.
$59
Phathom Pharmaceuticals, Inc.
$56
Medtronic MiniMed, Inc.
$50
AbbVie, Inc.
$50
Dexcom, Inc.
$49
ARBOR PHARMACEUTICALS, INC.
$48
Biohaven Pharmaceuticals, Inc.
$46
Nevro Corp.
$40
Esperion Therapeutics, Inc.
$38
IDORSIA PHARMACEUTICALS US INC
$37
Edwards Lifesciences Corporation
$34
Paratek Pharmaceuticals, Inc.
$33
Biohaven Pharmaceutical Holding Company Ltd.
$32
VIVUS, Inc.
$30
SANOFI PASTEUR INC.
$26
LIFESCAN, INC.
$25
Nalpropion Pharmaceuticals LLC
$25
MannKind Corporation
$24
ITI, Inc.
$23
Alnylam Pharmaceuticals Inc.
$23
Sumitomo Pharma America, Inc.
$21
Shire North American Group Inc
$20
ACADIA Pharmaceuticals Inc
$19
Arbor Pharmaceuticals, Inc.
$18
IBSA Pharma Inc.
$18
TheracosBio, LLC
$17
Insulet Corporation
$16
Lundbeck LLC
$14
Bausch Health US, LLC
$13
Nalpropion Pharmaceuticals, Inc.
$12
Medicure Pharma Inc.
$11
Orexigen Therapeutics, Inc.
$11
HOSPIRA, INC.
$8
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · APTIOM · AREXVY · Aimovig · Amitiza · Austedo XR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Belviq · Brenzavvy · CAMZYOS · CAPLYTA · CHANTIX · COMIRNATY · CONTRAVE · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre blood glucose Flash Monitoring System · GEMTESA · GLASSIA · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LOKELMA · LYRICA · Leqembi · Livalo · MOUNJARO · MYRBETRIQ · Minimed 530G · Minimed 630G · Motegrity · Myrbetriq · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · Nuedexta · OFEV · ONETOUCH VERIO FLEX · ONPATTRO · Omnia · Omnipod · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Prolia · QSYMIA · QULIPTA · QUVIVIQ · Qsymia · RAYOS · REXULTI · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tirosint · Tresiba · Trintellix · UBRELVY · UTIBRON · Uloric · Utibron · VERQUVO · VESICARE · VOQUEZNA · VRAYLAR · VYEPTI · VYNDAQEL · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri · ZEPBOUND · ZYPITAMAG (pitavastatin)
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
1,061
County median income
$70,156
Nearest hospital to ZIP centroid (approximate)
HERITAGE VALLEY BEAVER
7.4 mi
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gandhe is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gandhe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gandhe performed 267 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gandhe receive payments from pharmaceutical companies?
Yes. Dr. Gandhe received a total of $11,812 from 67 companies across 772 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gandhe's costs compare to other internal medicine physicians in Aliquippa?
Dr. Gandhe's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gandhe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Aliquippa
Browse internal medicine physicians in Aliquippa ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology